Alumni Capital LP's Schedule 13G Filing for Aethlon Medical Inc.

Alumni Capital LP, along with Alumni Capital GP LLC and Ashkan Mapar, filed a Schedule 13G on September 22, 2025, disclosing beneficial ownership of 9.58% of Aethlon Medical Inc.'s common stock. The filing indicates that Alumni Capital LP holds 781,110 shares, which includes shares that may be acquired through a Securities Purchase Agreement and a warrant dated September 4, 2025. The warrant allows the acquisition of shares up to 9.99% of the outstanding shares, subject to certain conditions. The filing is made under Rule 13d-1(c) and includes an agreement of joint filing among the reporting persons.